Wong To Yick Wood Lock Ointment Ltd v. Singapore Medicine Co. 星洲藥業 (A Firm) and Others
Read the full judgment text of HCA 600/2014 on BabelCite. This High Court CFI judgment was delivered on 8 April 2021.
1. The plaintiff claims against the defendants for:
Cited by 5 cases · Cites 10 cases
|
HCA 600/2014 [2021] HKCFI 920 IN THE HIGH COURT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION COURT OF FIRST INSTANCE ACTION NO 600 OF 2014 AND 595 OF 2014 ________________________
________________________ Before: Hon Wilson Chan J in Court Dates of Hearing: 29 to 31 October, 1, 4 to 6, 12, 14 November 2019; 25 and 26 August 2020 Date of Judgment: 8 April 2021 ________________________ J U D G M E N T ________________________ A. INTRODUCTION A1. The claims 1.The plaintiff claims against the defendants for:
2.The plaintiff seeks injunctions against the defendants together with ancillary orders including delivery up, discovery and an enquiry as to damages or an account of profits. A2. The plaintiff 3.The plaintiff was incorporated on 22 July 1988 to take over the business previously carried on and the goodwill previously built up and owned by Wong To Yick through business carried on by him under the trading names “中國跌打風濕醫館 (黃道益醫館) WONG TO YICK CLINIC” established in July 1967 and “China Medical Laboratory 中國醫館製藥廠” established in 1982 (the “Plaintiff’s Predecessor”). 4.The sole business of the Plaintiff’s Predecessor and the plaintiff was and is the manufacture and marketing of a medicated balm under the name “Wong To Yick Wood Lock Medicated Balm 黃道益活絡油” (the “Plaintiff’s Product”). A3. The defendants 5.The 5th defendant (“Law”) and the 6th defendant (“Mrs Law”) are husband and wife respectively and the 7th defendant (“Ms Law”) is their daughter. 6.The 1st defendant is a partnership trading under the name of Singapore Medicine Co 星洲藥業 carrying on business in the manufacture and sale of Chinese medicinal products including medicated oils and balm. The 2nd defendant, the 3rd defendant and the 5th defendant have been the partners or the sole proprietor of the business of the 1st defendant during various periods of time. 7.The 2nd defendant and the 3rd defendant are distributors of Chinese medicinal oils or balm. The 4th defendant is a manufacturer and distributor of Chinese medicinal products including medicated oils and balm. 8.Law is a director and shareholder of the 2nd to 4th defendants, whereas Mrs Law is the company secretary of the 2nd defendant and the 4th defendant, and a shareholder and director of the 3rd defendant. Law and his wife direct, control and are personally involved in the business activities and operations of the 1st to 4th defendants. 9.Ms Law has since 23 April 2012 adopted the trading name of Nanyang (Singapore) Trading Co and has carried on business in the distribution and sale of Chinese medicinal oils or balm. Ms Law is also a shareholder of the 2nd defendant. A4. The Plaintiff’s Get-up of “黄道益活絡油” 10.Since 1968, the Plaintiff’s Product has been manufactured and marketed under and by reference to the names and/or marks “黄道益” and/or “黄道益活絡油” (the “Plaintiff’s Marks”) in a distinctive get-up. Over the years, the get-up (the “Plaintiff’s Get-up”) has been revised from time to time but certain distinctive features since 1980s remain unchanged. Selected versions of the packaging are reproduced below for easy reference.
11.Over the years, the Plaintiff’s Marks and the Plaintiff’s Get-up have been used and promoted extensively in Hong Kong, in other countries around the world, and in particular, on mainland China by the plaintiff and the Plaintiff’s Predecessor. The sales turnover of the Plaintiff’s Product between 1 April 2012 and 31 March 2013 at wholesale level was HK$496.1 million. A5. The plaintiff’s registered trade mark 12.The plaintiff is the registered proprietor of the following trade marks in Hong Kong (the “Registered Trade Marks”):
13.It has been held by this court that substantial goodwill subsists in the marks “Wong To Yick”, “黃道益”, the distinctive get-up and the Registered Trade Marks: Wong To Yick Wood Lock Ointment Ltd v Sky Harvest Medicine Co Ltd [2018] 3 HKLRD 506, at paragraphs 1 and 2. B. THE PLAINTIFF’S CASE B1. Passing-off and trade mark infringement by the defendants 14.The 1st defendant and the 4th defendant have manufactured and the 2nd defendant, the 3rd defendant and the 7th defendant have distributed and sold the following medicated balm in get-ups and under names or marks which infringe the Registered Trade Marks and which are so deceptively similar to the Plaintiff’s Marks and the Plaintiff’s Get-up that their use by the defendants constitute acts of passing-off (the“Infringing Products”):
The names and/or marks “黃道人” and/or “黃道人 活絡油” and “黃道老人” and/or “黃道老人 活絡油” are hereinafter referred to as the“Infringing Marks”. 15.Further, after the issue of the Writs herein, Mrs Law on 27 May 2014 applied to register the mark “黃道” in Class 5 of the Register of Trade Marks under trade mark application number 303009177. Mrs Law withdrew the application in March 2019 after opposition from the plaintiff. 16.Between April and October 2016 and unknown to the plaintiff, Mrs Law applied to register the following marks in Class 5 of the Register of Trade Marks. Insofar as the plaintiff is aware, Mrs Law subsequently withdrew most of the applications in 2017 and 2018.
17.Mrs Law made another application to register the mark 18.The 4th defendant made an application to register the packaging on 15 June 2006 under trade mark application 300659241 and was subsequently withdrawn after opposition from the plaintiff in 2018. 19.The plaintiff submits that the said trade mark applications hereinabove are instruments of deception in that they are inherently deceptive by carrying indicia so close to the Plaintiff’s Marks, the Plaintiff’s Get-up and the Registered Trade Marks that they are bound to deceive, intended to mislead members of the public in Hong Kong, to believe, contrary to the fact, that products bearing the said marks are the products of and/or products licensed and/or endorsed by the plaintiff and/or associated with the plaintiff. B2. Intention to deceive 20.It is the plaintiff’s case that the defendants have deliberately and intentionally set out to deceive members of the public in Hong Kong and, in particular, visitors from mainland China to believe that the Infringing Products are the products of and/or products licensed and/or endorsed by the plaintiff and/or associated with the plaintiff by reason of the following:
B3. Similar facts evidence 21.In civil cases the courts will admit evidence of “similar facts” if it is logically probative, that is if it is logically relevant in determining the matter which is in issue: provided that it is not oppressive or unfair to the other side and also that the other side has fair notice of it and is able to deal with it. Therefore, whether the similarity between the Plaintiff’s Product and the Infringing Products is due to copying or a coincidence, it is relevant to know that the defendants have copied other products in the past: Mood Music Publishing Co Ltd v De Wolfe Ltd [1976] FSR 149 at 152; Copinger & Skone James onCopyright, 17th ed, Vol 1 at 21-393. 22.In HCMP 2026/1998 concerning an application by Ms Law Oi Ying (the sister of Law) to expunge a device trade mark comprising the picture of an ancient Chinese-style 3-legged covered cauldron registered in the name of the 4th defendant, Law as the 4th defendant’s director admitted that the said device mark was copied from a trade mark used by a third party on its medicated oil product, namely, Lou Fu Mountain Hundred Grass Oil (羅浮山百草油). 23.In HCA 1719/2010 regarding a claim brought by Pan Chung Pat Wo Tong (Hong Kong) Limited against Law who was trading as the 1st defendant at the material time for trademark infringement and passing-off, Law made the concession that the 1st defendant’s infringing product complained of was confusingly similar to the medicated oil 華陀油 (Wah Tor Yeow (Oil)) manufactured by Pan Chung Pat Wo Tong (Hong Kong) Limited and the “關陀像” mark adopted by Law on the said infringing product was confusingly similar to the Registered Trade Mark No 199708190 belonging to Pan Chung Pat Wo Tong (Hong Kong) Limited. One of the issues for trial was whether Law acted in bad faith when he applied for registration of the mark “百和堂”. Law elected not to give any evidence or call any witnesses. Before closing submissions, Law submitted to Judgment. B4. Instances of deception 24.There have been instances of deception caused by the use of “黃道老人” on medicated balm in the market. B5. Joint tortfeasors 25.It is the plaintiff’s case that each of the acts complained of against the 1st to 4th defendants was directed, authorised, counselled or procured to be done by both Law and Mrs Law who render themselves jointly and severally liable for the infringing acts of the 1st defendant to the 4th defendant. 26.Alternatively, all the defendants committed the acts complained of pursuant to a common design and each of them should be liable as joint-tortfeasors. C. THE DEFENDANTS’ PLEADED CASE C1. The Plaintiff’s Get-up consists of mostly “common features” 27.The defendants’ pleaded case is that the Plaintiff’s Get-up consists mostly of common features in the trade that are easily distinguishable and would not cause confusion. The plaintiff submits there is no merit in this plea because it is the plaintiff’s case that the Plaintiff’s Get-up is distinguished by the combination of the features identified in the Statement of Claim in which the overall visual effect is to be appreciated as a whole. The comparison Tables A-G put forward by the defendants totally ignores the rules of comparison and dwell on matters of no trade mark significance. 28.Mrs Law’s testimony on this topic is contained in her 2 witness statements. 29.Insofar as the book Hong Kong Apothecary is concerned, Mrs Law was unable to point to any matter therein in support of her allegation that the distinctive features of the Plaintiff’s Get-up are very common in the Chinese medicine trade. 30.Mrs Law has also confirmed that what connection the characters 黃道 may have had with Taoism had nothing to do with why the Laws chose 黃道人 as a product name. All those internet materials in this regard are thus irrelevant. 31.In their Defence, the defendants rely on some products on the market which allegedly have been around since 1 March 1999 to say they incorporate similar features to the Plaintiff’s Get-up. In her witness statements, Mrs Law did not even deal with this aspect of the defendants’ case other than making a very general statement of no evidential value whatsoever: “I also visit shops in the market from time to time and found that there are packaging of many Chinese medicinal oil products incorporating similar features to the Plaintiff’s products”. 32.There is not a shred of independent and objective evidence from the defendants who bear the evidential burden to support the allegation that any of these products have been on the market since 1 March 1999. Neither invoices nor witnesses from the trade have been put forward in support. 33.All that the defendants could muster is that one product, “Wong Fu Chi” (黃夫子) has a HKP number on it and so it was put to the plaintiff’s witness Wong Wei Kin Cathy (“Cathy Wong”) that this product was on the market before 1999. However, this premise is false and unreliable. Firstly, it is not known whether the HKP number is genuine and in respect of what product was it registered. Secondly, it has an expiry date of 2019 and thus could not have been on the market before 1999. 34.The evidence-in-chief and the cross-examination of Cathy Wong has dealt with this aspect of the defendants’ evidence and they have been summarized by the plaintiff as follows:
C2. Estoppel/acquiescence/delay 35.It is pleaded by the defendants that (a) the 1st defendant and the 4th defendant have openly and publicly offered the Infringing Products to the public since the mid-1990s, ie there was use of the Infringing Products since the mid-1990s; and (b) applications were made in 2004 to register the Infringing Products with the Chinese Medicine Council (“CMC”) under 3 application numbers: HKP01403 and HKP01405 in the name of the 1st defendant and HKP04101 in the name of the 4th defendant. 36.The defendants allege they had been led by the lengthy period of inaction by the plaintiff into assuming the plaintiff did not object to the defendants’ use of the mark/name 黃道人and the defendants’ packaging. Therefore, the defendants had continued to invest time, effort and money towards establishing their business by reference to 黃道人. The defendants thus rely on some sort of estoppel arising from the alleged acquiescence and delay which have caused the defendants to assume to their detriment the plaintiff would not take any action. 37.When particulars were requested, the answers supplied were vague or the response was that the particulars sought were matters of evidence. After many rounds of discovery, there is neither a shred of credible evidence to demonstrate that the Infringing Products have been sold since the 1990s (ie no evidence of use since 1990s) nor have they been registered with the CMC since 2004 as alleged. 38.This is the main plank of the defendants’ case. It is alleged that the 1st defendant and the 4th defendant were selling the Infringing Products prior to March 1999. In support of this, they rely on applications submitted to the Department of Health (“DOH”) in 2004 under the auspices of a grand-fathering regulatory policy, which required a mere assertion to be made that a medicinal oil product has been sold in the Hong Kong market by the applicant for more than 5 years, with some prima facie proof of the same in the form of invoices and the packaging in use. 39.Common sense and logic would dictate that any trader in Chinese medicinal products making a bona fide application would submit the packaging of what they had actually been selling on the market in the 1990s together with their application in 2004 given the importance of this cut-off date. One must bear in mind that these forms were devised with Chinese medicine traders in mind and not scientists and pharmaceutical companies. Mr Law seemed to have no difficulty filling in the forms - in fact he filed over a hundred applications for the 1st defendant and the 4th defendant. As the plaintiff’s witness Chan Siu Fung Jackel (“Jackel Chan”) had pointed out in his evidence, the 1st defendant and the 4th defendant claimed to have frequently sent representative to attend talks given by DOH. There would have been no reason for the defendants not to have submitted packagings of the Infringing Products with the applications in 2004 if indeed they were on the market even in 2004 or been sold since before 1999, as claimed in the application submitted. 40.How the defendants have put forward this aspect of the case and how the documents in Bundles C3 to C5 have been disclosed is also highly suspect. First of all, Mrs Law has given no credible explanation as to why the Consolidated Defence was different from the original defence. Her answer was that she told her lawyers but she did not know why they did not plead it. This answer is simply incredible. Secondly, as submitted by the plaintiff, the documents in Bundles C3 to C5 were disclosed in dribs and drabs. 41.The documents at Bundle C1/54 (Annex E to H) and C1/63 (Annex B to C) were disclosed on 6 December 2016. The application documents of the Infringing Products at Annex D were not disclosed until much later. As a result of the disclosure, Jackel Chan analyzed them and filed his witness statement on 29 March 2017 where he came to the conclusion that the documents did not support the defence case. It is important to note that Mrs Law in her first witness statement of 29 March 2017 only made the briefest of all references to these documents that form the core of the defence. 42.The second batch of discovery was given by the defendants on 29 March 2017, the same day the witness statements were exchanged. These are the documents at Bundle C2/270 (Annex E to H), C2/261 (Annex B to C) and C2/239 (Annex D). Jackel Chan analyzed this batch of documents and filed his supplemental witness statement on 12 July 2017 with the conclusion that the disclosed documents do not support the pleaded case at all. It was only on 30 November 2017 that the defendants disclosed what are now Bundles C3 to C5. 43.Mrs Law filed her supplemental witness statement on 30 November 2017 but it was dated 13 October 2017 referring to some of the documents at Bundles C3 to C5. This demonstrates the defendants were hanging onto Bundles C3 to C5 since at least October 2017. The supplemental witness statement of Mrs Law did not even attempt to deal with the criticisms of Jackel Chan but dealt with these very important matters to the defence case in a token manner and broad-brush approach. It is incumbent on the defendants to (1) make good their defence by explaining these documents and the process of application and (2) to answer the criticisms of Jackel Chan which they had failed to do for the simple reason that the documents do not support their pleaded case. 44.Jackel Chan was cross-examined extensively on his witness statements and Bundles C3 to C5. I agree his evidence was convincing and firm and the key takeaways of his evidence are:
45.The testimony of Jackel Chan and the cross-examination of Mrs Law show that the applications were made not in respect of the Infringing Products but the applications were amended many times and metamorphosed over the course of 5 to 7 years into products which were vastly different from that in the original applications. 46.Some points from the testimony of Jackel Chan and Mrs Law should be highlighted. C2(a). Bundle C3 - HKP-01403 - Annex B & C 47.Mrs Law’s evidence was that the packaging at [C1/66-67] was the product packaging referred to in the invoices at [C1/61]. This certainly cannot be the case because the packaging was printed with year 2000 and “Manufactured by Singapore Medicine” “o/b Good Prestige Ltd” thereon. Good Prestige Ltd was only incorporated in the year 2000 and the directors and shareholders were not the Laws. Mrs Law tried to explain this inconsistency by saying that the drug store asked the defendants to produce this product in their name. When questioned on how that would make any sense, Mrs Law changed her testimony again to that the packaging was new from 1999 or 2000 because the packaging says 2000. These documents and the evidence of Mrs Law are totally unreliable and do not support the defendants’ case. There is therefore no evidence that this was the defendants’ product (as they represented to DOH it was) or that it was indeed sold by them in Hong Kong since 1999 or any subsequent time. 48.Jackel Chan made this pertinent observation: if the packaging was submitted with the application, the defendants have not explained why they did not amend the packaging by cutting and pasting as they have done with all the other packaging amendments, but submitted an entirely different packaging on 18 November 2009 [C3/496], curiously reverting from a relatively modern packaging to a much older style packaging resembling the plaintiff’s packaging. 49.Insofar as the Infringing Product at Annex B is concerned, Mrs Law said in cross-examination that it was first put on the market after 2004 and not in the 1990s. This statement cannot be true because the packaging identical to Annex B was only submitted to DOH on 9 July 2013 [C3/531]. 50.Mrs Law’s initial testimony was that the packaging at Annex C was put on the market in 1999. On the next day, the evidence was then changed to “it was the packaging of 1997” and later “1997 or 1998”. This bare allegation and the constant shift in testimony is uncorroborated by any objective and independent evidence. 51.The defendants have not disclosed any sales invoices to retailers or orders for printing these packaging from their two long time printers and no representatives from local dispensaries were called. The defendants did not even contact their two long-serving salespersons, Yau and Chan who had been working for the 1st defendant and the 4th defendant since the 1980s and 1990s respectively. Finally, no evidence was adduced to show Annex C was even submitted to DOH for approval. An adverse inference should be drawn to the effect that if these persons had been called, their evidence would not have assisted the defendants – Li Sau Keung v Maxcredit Engineering Ltd [2004] 1 HKC 434 at §§28-29. C2(b). Bundle C4 - HKP-04101 - Annex E, F, G & H 52.The key takeaways from the evidence of Jackel Chan are:
53.During the cross-examination of Mrs Law, she initially stated that Annex E, F and G were put on the market in 2006. However, after a long and difficult cross-examination on this topic because Mrs Law refused to give straight answers to simple questions, she finally admitted that Annex E and F were put on the market in 2011 and after 2011 respectively. 54.Insofar as Annex H is concerned, the product name was not even 正宗老人 but 南洋活絡油 at the time of application. 正宗老人 only first appeared in 2012 in a submission for amendment despite Mrs Law’s knowledge of the requirement to submit packaging before the cut-off date in 1999. C2(c). Bundle C5 - HKP-01405 - Annex D 55.There was really no cross-examination of Jackel Chan on this topic. Jackel Chan in re-examination testified that even after the product name had been changed by subsequent amendments, 黃道老人 was never a part of the product name of the application. Mrs Law admitted in cross-examination that the Infringing Product in Annex D was put on the market in 2012 and not according to her pleaded case, ie since the mid-1990s. 56.In summary, the following points can be noted from Bundles C3 to C5 and the oral testimony:
D. PASSING-OFF 57.The basic principles of passing-off require proof of a goodwill in a business in the supply of goods (or services) distinguished by a name or mark or get-up that has been or likely will be damaged by the conduct of another and such conduct ismisleading or deceptive of the public. This principle is restated by the Court ofFinal Appeal in Re Ping An Securities Ltd (2009) 12 HKCFAR 808 at §17. There, the court followed Reckitt & Colman Products Ltd v Borden Inc [1990] RPC 341 at 406. In particular, Gault NPJ giving the Judgment of the Court of Final Appeal cited with approval the speech of Lord Oliver in Reckitt & Colman where his Lordship stated the trinity of passing-off as:
58.In The Commissioners of Inland Revenue v Muller & Co’s Margarine Ltd [1901] AC 217 at 223-224, Lord MacNaghten defined goodwill as:
59.The term “get-up” has been defined by the Supreme Court of Canada in Ciba-Geigy Canada Ltd v Apotex Inc [1992] 3 SCR 120 at 138:
60.The relevant time to determine whether a plaintiff has established the necessary goodwill or reputation is the date of the commencement of the defendant’s conduct complained of – Cadbury-Schweppes Pty Ltd v The Pub Squash Co Ltd [1981] RPC 429 at 494. Insofar as the plaintiff is aware, the defendants started their alleged infringing activities in 2012. 61.United Biscuits (UK) Ltd v Asda Stores Ltd [1997] RPC 513, was a case involving get-up where the plaintiff sued the defendant for passing-off its Puffin biscuits as the plaintiff’s Penguin biscuits. Robert Parker J set out the following general principles which are highly relevant to the present action:
62.The imitation of a number of things, each of which is in itself not distinctive of a plaintiff’s goods, may make a strong case of passing-off on the account of the cumulative effect of the detailed resemblances. The taking by a defendant of a word or words, which though not distinctive, form a prominent part of the plaintiff’s label, may strongly contribute to the passing-off - Kerly’s Law of Trade Marks and Trade Names, 16th ed, §20-175. 63.In considering the question of likelihood of confusion or deception, the court is entitled to give effect to its own opinion and is not confined to evidence of witnesses called at trial – Neutrogena Corp & Anor v Golden Ltd & Anor [1996] RPC 473 at 495-496. 64.Proof of actual confusion or deception, if the mark or get-up in question is in the opinion of the court likely to confuse or deceive, is unnecessary. It is seldom the case that all instances of confusion or deception will come to light. The more perfect the deception, the less likely that will be so. Nevertheless, if there is evidence of actual confusion or deception, this will afford very strong evidence that the resemblance between the marks in question is so close as to be likely to confuse or deceive. Thus, evidence of actual confusion is always relevant and may be decisive, whilst absence of such evidence may often be readily explained and is rarely decisive - Neutrogena Corp, ibid, at 482; Harrods Ltd v Harrodian School Ltd [1996] RPC 697 at 716. 65.In assessing a case of passing-off by imitation of get-up, one postulates that the average purchaser is neither the very careful nor the very careless buyer but an average purchaser, who has a general idea in his mind’s eye of what he means to get but not an exact and accurate representation of it. Nor will he necessarily have the advantage of seeing the two products side by side. Nor will he be alerted to single out the fine points of distinction or definition. Although the law of passing-off is not designed to grant monopolies in successful get-ups, the moment a party copies he is in danger and he escapes liability only if he makes it “perfectly clear” to the public that the articles which he is selling are not the other manufacturer’s, but his own articles, so that there is no probability of any ordinary purchaser being deceived – Blue Lion Manufacturing (Pty) Ltd v National Brands Ltd [2001] (3) SA 885 (SCA) at §§3 & 4. 66.Under the principle of imperfect recollection,
67.Indeed, the questions to be asked in every case when assessing the likelihood of confusion are the background of the type of market in which the goods are sold, the manner in which they are sold and the habits and characteristics of purchasers in that market - Reckitt & Colman, supra, at 415-416. 68.Unless the circumstances of a case suggest otherwise, the court is entitled to find, if passing-off is established, that the plaintiff has suffered some damage – Henderson v Radio Corporation Pty Ltd [1969] RPC 218 at 241-242. In the present action, once misrepresentation has been proved, there cannot be any doubt that damage has been suffered by the plaintiff, in particular in the diversion of sales to the defendants and also in the dilution of the exclusivity of the Plaintiff’s Marks and the Plaintiff’s Get-up. 69.It is passing-off for a defendant to put into circulation goods which are inherently likely to deceive consumers even though the immediate purchasers maybe middlemen who are not themselves deceived and even though the middlemen may ultimately dispose of the goods in a manner which does not deceive anyone at all. The tort is complete when the defendant parts with possession of the deceptive goods – Lever v Goodwin 4 RPC 492 at 507; Draper v Trist 56 RPC 429 at 435. (See: The Law of Passing Off by Professor Christopher Wadlow, 5th ed, at §5-137.) 70.The concept of instruments of deception also applies to intangibles such as company names, internet domain name registrations and trade mark registrations. A name which is, by reason of its similarity to another name, inherently likely to lead to passing-off is an instrument of deception – British Telecommunications v One In A Million Ltd [1999] FSR 1 at 18 & 23-24. 71.Deception is the central element of the tort of passing-off. It is not necessary for a plaintiff to establish that the defendant consciously intended to deceive the public as a probable result of his conduct. Nevertheless, the question why the defendant chose to adopt a particular name or get up is always highly relevant. If it is shown that the defendant deliberately sought to take benefit of the plaintiff’s goodwill for himself, the court will not “be astute to say that he cannot succeed in doing what he is straining every nerve to do” – Slazenger & Sons v Feltham & Co (1889) 6 RPC 531 at 538; Harrods Ltd, supra, at 706. 72.Where a trader, having knowledge of a particular market, borrows aspects of a competitor’s get-up, it is a reasonable inference that he believes there will be a market benefit in so doing. The obvious benefit will be the attraction of custom which would have otherwise gone to the competitor. It is an available inference that the trader considered that such borrowing was fitted for the purpose and therefore likely to deceive or confuse. Such copying may well be of only part of the competitor’s get-up. – Sydneywide Distributors Pty Ltd v Red Bull Australia Pty Ltd [2002] FCAFC 157 at §§117 & 121. D1. Goodwill 73.The defendant has conceded in its Opening that the plaintiff has goodwill in the word mark and Get-up. In addition, Mrs Law had admitted in cross-examination that there is substantial goodwill in the “黄道益” trade mark and the Plaintiff’s Get-up. That should have been sufficient to put the issue to rest. However, during cross-examination of Cathy Wong and being opportunistic, the defendants’ counsel tried to raise some opaque and unpleaded point relating to the plaintiff’s goodwill. 74.It is trite that goodwill is territorial. The plaintiff is not suing on the goodwill in USA, Singapore or mainland China but on the goodwill in Hong Kong. The acts of infringement were all committed in Hong Kong. When Mainlanders visit Hong Kong to buy their desired product, they are looking for the Hong Kong products in the Hong Kong packaging, not some Mainland packaging that they knew were available on the Mainland. The “attractive force” relied on by the plaintiff is the Hong Kong goodwill, ie indicia of origin by way of the Hong Kong packaging, which the Mainland shopper believes is superior to the Mainland equivalent products. To suggest that they would be looking in Hong Kong for some “packaging sold on the Mainland” (referred to as “Tinly’s packaging”) is a failure to understand the evidence. 75.Mainlanders and the public in Hong Kong are familiar with the Plaintiff’s Get-up and there is no evidence to suggest otherwise. An article of 28 May 2012 in Nanfeng (Southern) City Post describes how mainlanders love to buy over the counter medicines in Hong Kong because they are relatively cheap and of good quality and the Plaintiff’s Product was discussed. On the top of the list is an image of the Plaintiff’s Product. 76.The defendants’ Written Closing says that the plaintiff no longer has goodwill in the blue and white packaging. There is no positively pleaded defence of abandonment and extinction of such goodwill, just a last-minute tactical maneuver to take advantage of the litigation within the family by relying on the Judgment of Lam J (as Lam VP then was) disclosed only shortly before the trial[1] to formulate a speculative theory of the vanishment of goodwill in the blue and white packaging. Further, the assertion is again factually incorrect because Mrs Law admitted to the plaintiff’s goodwill. D2. Copying and misrepresentation 77.The issues of copying and misrepresentation are intertwined. 78.The gist of the evidence of Mrs law is as follows:
79.The evidence above has to be seen and contrasted with the defendants’ flagship brands 金大班, 虎頭標 and 星洲. Their names and packaging do not resemble the Plaintiff’s Product at all and they stand out prominently in their own right. 80.In the premises, I agree that the evidence irresistibly points to one single conclusion: the purpose of copying the surname 黃 and the Plaintiff’s Get-up is to deceive consumers into believing the Infringing Products are somehow related to the plaintiff and providing retailers with a spectrum of deceptive packaging is to allow retailers to sell the Infringing Products without having to compete with each other on the price. 81.The conclusion at paragraph 80 above is further supported by the following facts and matters:
82.On the issue of deceptive similarity/misrepresentation, the defendants have denied having had an intention to deceive. However, if one reads paragraph 13 of the Consolidated Defence carefully, the defendants have not positively denied copying nor pleaded a case of independent creation. There remains no explanation how the Infringing Marks and the packaging of the Infringing Products were devised. 83.This is to be considered against the objectively striking resemblance between the Infringing Marks, the get-up of the Infringing Products with the Plaintiff’s Marks, the Registered Trade Marks and the Plaintiff’s Get-up and they include the particulars of Deceptive Similarity pleaded and the matters hereinbelow:
84.The defendants have denied that the Infringing Products are confusingly and deceptively similar and have put forward various arguments as to why they so contend. The defendants have put forward 41 pages of detailed and minute comparison in table form which, as submitted by the plaintiff, is pointless and completely ignores the rules of comparison. Such arguments put forward by the defendants are wholly unconvincing and without merit. 85.The fact that Mrs Law had initially applied to register the mark “黃道” in Class 5 in 2014 after the Writs were issued and not “黃道人” or “黃道老人” negates the argument that any distinctiveness of the Infringing Marks comes from the combination of all 3 or 4 characters of the Infringing Marks. The subsequent applications to register the Infringing Marks “黃道人” or “黃道老人” in 2016 is merely an afterthought. 86.Further, by reason of the similarities between the Infringing Products at Annex E, F and G and the plaintiff’s “1993” packaging including but not limited to the incorporation of the seal of identical shape and Chinese characters therein (93 new packaging), such similarities cannot be explained and has not been explained except by a deliberate attempt on the part of the defendants to appropriate the goodwill of the Plaintiff’s Marks and the Plaintiff’s Get-up especially when the 4th defendant, the manufacturer named on the packaging only commenced business on 27 June 1996. 87.Applying the global appreciation test, I agree with the plaintiff’s submission that the Infringing Marks and the Infringing Products are visually, aurally and conceptually similar to the Registered Trade Marks. By reason of the highly distinctive character of the Registered Trade Marks through use, the likelihood of confusion will be enhanced. It is also the plaintiff’s case that the defendants have copied the Registered Trade Marks/the Plaintiff’s Get-up/the Plaintiff’s Marks. 88.The defendants identified 4 key features of the Infringing Products which are allegedly clear differences apparent to anyone. These alleged 4 key features do not serve to distinguish in law and in fact. Insofar as the name, 星洲藥業 SINGAPORE MEDICINE CO appearing on the Infringing Products is concerned, the law is that whether the public is aware of the plaintiff’s identity as the manufacturer of the goods is immaterial, as long as they are identified with a particular source. It matters not at all that there is little or no public awareness of the identity of the proprietor of the brand name. The confusion as to origin in passing-off is confusion as to origin of the indicia in which goodwill subsists, not confusion as to who is the manufacturer or proprietor of the indicia because consumers may not know and may not care who the manufacturer or proprietor is. 89.Insofar as the appearance of Chinese medicine registration numbers appearing on the Infringing Products are concerned, there is no evidence that consumers rely on Chinese medicine registration numbers to distinguish medicinal oils from one another rather than the brand name and get-up. Indeed, common sense would say otherwise. Insofar as the strip opener with Singapore Medicine marked on it is concerned, the Plaintiff’s Product has the same strip opener feature. 90.To argue that the image of the old man looks entirely different from Mr Wong To Yick and therefore distinguishes the Infringing Products is really scraping the bottom of the barrel. This argument does not take into account of the rules of comparison which includes imperfect recollection. Further, such an argument does not exclude the possibility that the public would assume an association in the form of a common manufacturer or the Infringing Products are manufactured under licence from the source of the Plaintiff’s Product. 91.The defendants have been relying on cases where there was evidence of confusion. The absence or presence of evidence of confusion is not conclusive. Ultimately, the question of likelihood of confusion is a matter for the tribunal of fact taking into account all the circumstances, and not for any witness. D3. Instruments of deception 92.Insofar as category 1 of instruments of deception are concerned, ie goods which are inherently deceptive in that they carry indicia so close to what is distinctive of the plaintiff that they are bound to deceive unless specific remedial measures are taken, the plaintiff relies on the matters set out in paragraphs 77 to 91 above. I agree with the plaintiff’s submission that the Infringing Products are inherently deceptive. 93.Insofar as category 2 is concerned, ie goods which do not deceive unless the retailer was responsible for a further misrepresentation of his own, but which are still close enough to those of the plaintiff in their distinctive features for this to be facilitated. It may be assumed that if the defendants supply goods which just fall short of being inherently deceptive intending that they will be passed off by the retailers then they will be liable. 94.There is testimony from Mrs Law to the effect that the products the defendants make are driven by the demands of the market ie what retailers want. Retailers would want products that would sell and Mrs Law knew what was happening in the market place and how retailers were committing switch-selling of famous medicinal brands. And despite having such knowledge she continued to supply the Infringing Products to retailers. 95.The blogposts demonstrate that the Infringing Products are instruments of deception and that is what has been pleaded in the Reply. E. TRADE MARK INFRINGEMENT E1. Section 18(3) of the TMO 96.Under section 18(3) of the TMO:
97.“Use” is defined in TMO section 18(5):
98.The principles to be applied in assessing the likelihood of confusion under section 18(3) TMO have been laid down and developed in a number of decisions of the European Court of Justice and of the UK courts, in particular, Sabel v Puma [1998] RPC 199; Canon Kabushiki Kaisha v Metro-Goldwyn-Mayer Inc. [1999] RPC 117; Lloyd Schuhfabrik Meyer & Co GmbH v Klijsen Handel B.V. [2000] FSR 77 and Specsavers International Healthcare Ltd v Asda Stores Ltd [2012] FSR 19, at §§51-52, 87. These principles have been applied and followed in the Hong Kong Court of Appeal - Tsit Wing (Hong Kong) Co Ltd v TWG Tea Co Pte Ltd [2015] 1 HKLRD 414 at §§33-38. 99.The principles are:
100.The concept of what constitutes a likelihood of confusion on the part of the public was discussed by the Court of Final Appeal in Tsit Wing (Hong Kong) Co Ltd v TWG Tea Co Pte Ltd (No 2) (2016) 19 HKCFAR 20. Gummow NPJ held at §44 that “while a mere possibility of confusion is not enough, it is sufficient if the result of use by the defendant of the sign in question will be that a number of ordinary persons will entertain a reasonable doubt and be caused to wonder whether it might not be the case that the goods or services in respect of which the defendant’s sign is used have the same provenance as those in respect of which the trade mark is used.” Thus, it can be seen that the threshold of demonstrating a likelihood of confusion is not high. 101.An additional factor in the global appreciation test is the intention of the defendant, who as a person who knows the market in which he is offering his good or services. Thus whether the defendant copied the Plaintiff’s Mark or deliberately sailed close to the wind are factors that should be taken into account - Specsavers International Healthcare Ltd, supra, §115-116. 102.In Portakabin Ltd v Powerblast Ltd [1990] RPC 471 at 480, Mummery J in comparing the marks Portoblast and Porta, had regard to the idea of the mark and said that “the addition of the next five letters, “blast”, in the defendant’s mark, does not diminish the resemblance of “portoblast” to the registered mark “porta” in its essential features of idea.” 103.For the purposes of section 18(3), the court has to assume even if it were not so in fact that the mark owner has a reputation and goodwill in his mark. In other words, the court has to assume that the mark has been in use and developed a reputation and goodwill for the entire specification of goods or services. This is what distinguishes registered trade mark rights from the common law right of passing-off. The former confers protection ahead of use. Infringement will occur irrespective of any use – the mark may not have been used at all. The kind of use contemplated when a mark is unused or minimally used has to be that of notional and fair use. When the mark sued upon has actually been used on a substantial scale, one can take that actual use into account in assessing its distinctiveness but it does not limit the circumstances under which confusion may occur – Reed Executive Plc v Reed Business Information Ltd [2004] RPC 40 at §§79-81. 104.Proof of actual deception is unnecessary. If one or more cases of actual deception are made out to the satisfaction of the court, this will be very strong evidence that the resemblance between the marks in question is so close as to be likely to deceive –Kerly’s Law of Trade Marks and Trade Names, 16th ed, §23-019. 105.The Registered Trade Marks are set out at paragraph 12 above. The Packaging Trade Mark is registered in respect of monochrome as well, hence it is treated as registered in respect of all colours. 106.The plaintiff submits that Annex B to H are infringements of the 黃道益 mark by reason of the testimony of Cathy Wong at paragraph 90 of her witness statement. Her testimony has not been challenged. 107.Insofar as the distinctive features of the Packaging Mark are concerned, I agree they are similar to the distinctive features of the Plaintiff’s Get-up. While such features and their overall visual effect are to be appreciated visually, they are described hereinbelow for the purpose of identification:
108.The distinctive and dominant component of the Packaging Mark is 黃道益 because words speak louder than devices and this is how the Packaging Trade Mark would be referred to by consumers. 109.In coming to the view that there is a high likelihood of confusion, this court accepts the following points which have been highlighted by the plaintiff:
E2. Section 18(4) of the TMO 110.Section 18(4) of the TMO prohibits a type of infringement which can be established without any actual confusion being demonstrated:
111.Although the wording suggests that the application of the sub-section is confined to the use of the similar mark on goods or services “not identical or similar” to those for which the well-known mark is registered, it has been authoritatively decided that it ought to be read to apply to the use by the defendant on goods and services “whether or not similar or identical”: Adidas-Salomon AG v Fitness World Trading Ltd [2004] FSR 21 §13-22,which has been followed in Hong Kong in Christie Manson & Woods Ltd v Chritrs (Group) Ltd [2012] 5 HKLRD 829 §51. 112.To satisfy section 18(4)(b), section 4(1) provides that:
113.The plaintiff clearly satisfies section 4(1)(c) having carried on business in Hong Kong for many years. 114.As to whether the Registered Trade Marks are well known, Schedule 2 of the TMO sets out the factors for consideration:
115.The plaintiff relies on the following in support of the contention, which is accepted by this court, that the Registered Trade Marks are well-known marks within the meaning of Schedule 2 of the TMO:
E2(a). Whether there is a link between the Registered Trade Marks and the Infringing Marks and Infringing Products 116.What needs to be proved is that due to the degree of visual, aural or conceptual similarity between the Registered Trade Marks and the Infringing Marks and Infringing Products, the public makes a connection or establishes a link between the two even though it does not confuse them. When the average consumer upon seeing the Infringing Marks and Infringing Products calls the Registered Trade Marks to mind, it is tantamount to the existence of such a link. In a case where confusion is established, there must a fortiori be such a link. 117.The plaintiff relies on the following facts and matters in support of the contention, which is accepted by this court, that the requisite link has been established:
E2(b). Unfair advantage 118.The matters and evidence referred to in 77 to 95 above clearly demonstrate the defendants intended to take unfair advantage by riding on the coat-tails of the Registered Trade Marks. E2(c). Without Due Cause & section 4(3) defence in Schedule 5 of TMO 119.The defendants have not adduced any evidence of “due cause” and there is no credible evidence of the use of 黃道人 and the Infringing Packaging prior to 4 March 2003. F. JOINT TORTFEASANCE 120.I agree there is a mountain of evidence to show the defendants are joint tortfeasors acting under a common design. Besides Mrs Law having admitted that Law and her had copied the Plaintiff’s Get-up and 黃道益name, the following are additional evidence demonstrating joint tortfeasance under a common design:
121.The submission that the 2nd defendant and the 3rd defendant are simply holding companies is plainly wrong. The 1st defendant is not a legal person. The 2nd defendant and the 3rd defendant carry on business in the name and style of the 1st defendant, and Mrs Law in her witness statement has admitted the 2nd defendant and the 3rd defendant are not mere holding companies. G. CONCLUSION 122.By reason of the matters stated above, judgment should be entered in favour of the plaintiff against the defendants for passing-off and trade mark infringement under section 18(3) and (4) of the TMO, for injunctive relief with ancillary orders including delivery up, discovery and an enquiry as to damages or an account of profits. 123.The precise terms of the judgment are to be agreed by the parties within 28 days from the date hereof, failing which, there be leave to the parties to lodge and exchange within 28 days thereafter written submissions on the terms of the judgment, and the matter is to be determined on the papers. 124.The costs of these proceedings (including all costs reserved, if any) be paid by the defendants to the plaintiff, such costs are to be taxed if not agreed with a certificate for 2 counsel. 125.The above order as to costs is nisi and shall become absolute in the absence of any application within 28 days to vary the same. 126.Lastly, I express my gratitude to counsel on both sides for their helpful assistance in this matter.
Ms Winnie Tam, SC, leading Mr Colin Shipp, instructed by Messrs William W L Fan & Co, for the plaintiff Mr Douglas Clark, instructed by Messrs Benny Kong & Tsai, for the 1st to the 7th defendants
[1] In the 5th Supplemental List dated 2 October 2019 at C7/1277. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cases cited in this judgment
Other judgments that cite this case
Further hearings and rulings under HCA 600/2014










under application 303945835 and according to the latest search, the status of the application is pending. 






